| Identification | Back Directory | [Name]
3β,7β,15β-trihydroxy-11-oxo-lanosta-8-en-24→20 lactone | [CAS]
1694587-15-9 | [Synonyms]
3β,7β,15β-trihydroxy-11-oxo-lanosta-8-en-24&rarr
3β,7β,15β-trihydroxy-11-oxo-lanosta-8-en-24→20 lactone
3β,7β,15β-trihydroxy-11-oxo-lanosta-8-en-24→20 lactone
3beta,7beta,15beta-trihydroxy-11-oxo-lanosta-8-en-24->20 lactone
Chol-8-en-24-oic acid, 3,7,15,20-tetrahydroxy-4,4,14-trimethyl-11-oxo-, γ-lactone, (3β,5α,7β,15β,20ξ)-
(3beta,5alpha,7beta,15beta,20xi)-3,7,15,20-Tetrahydroxy-4,4,14-trimethyl-11-oxo-chol-8-en-24-oic acid gamma-lactone | [Molecular Formula]
C27H40O6 | [MDL Number]
MFCD30748206 | [MOL File]
1694587-15-9.mol | [Molecular Weight]
460.6 |
| Hazard Information | Back Directory | [Uses]
3β,7β,15β-Trihydroxy-11-oxo-lanosta-8-en-24→20 lactone is a natural compound that could be isolated from G. lucidum with antimycobacterial activity. | [References]
[1] By Li, et al. Pharmaceutical compounds separated and extracted from Ganoderma lucidum and method and uses thereof. Patent CN 104478983 A. |
|
|